Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Stephen G. Dilly, M.D.$194M
Market Cap • 17/04/20242002
(há 22 anos)
2010
(14 years ago)
NASDAQ
Listagem
Redwood
Sede • California248
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CDXSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.